Tag Archives: Barack Obama

Getting it Done in Washington

During his fifth State of the Union address, President Obama struck many familiar chords – including a line about ending certain subsidies to pharmaceutical companies – and emphasized, repeatedly, the need to get things done on the policy front. Will the sequestration drum beat goad members of the 113th Congress onto the dance floor?
Posted in Legal, R&D, Strategy, healthcare, pricing | Also tagged , , , , , , | Leave a comment

The Yin and Yang of the Court Decision on HCR

by Tom Norton If you’re like me, you probably bounded out of bed on Thursday morning, took in all the news you could find about the Supreme Court and healthcare reform…and then you waited.  You waited patiently for the biggest legal call in American healthcare history.  And then, there it was. What did we learn?  Well, first, [...]
Posted in FDA, Legal, Market Access, Regulatory, Strategy, healthcare, leadership | Also tagged , , , | 1 Comment

Does Pharma Have a Debt Crisis Strategy?

The Obama Administration’s proposed fiscal budget for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default emerged as the [...]
Posted in Corporate Responsibility, Europe, Global, Strategy, healthcare, leadership, pricing | Also tagged , , , , | 1 Comment

Elmendorf Refuses to Go Quietly Into the Night of HCR

Guest Blog by Tom Norton of NHD Smart Communications. You can reach him at tnorton@nhdcomm.com. Amidst all the gurgling of oil last week(bad! bad! bad!), a competing thunderstorm of words erupted as Doug Elmendorf, Director of CBO, had the temerity to revisit the real costs of the new HCR law. Addressing something that, for whatever reason, [...]
Posted in Guest Blog | Also tagged , , , , , , | 2 Comments

Obama Reveals Healthcare Reform Plan

Image via Wikipedia The health reform proposal unveiled by the White House on Feb. 22, 2010 retains a number of provisions that directly affect drug coverage and industry revenues. The plan highlights that it will close the Medicare drug benefit “doughnut hole” by 2020 to make drugs more affordable to the elderly. Seniors will get some [...]
Posted in News, Regulatory | Also tagged , , , , | 4 Comments